Youcare Pharmaceutical Group Co. Ltd. A (688658) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Youcare Pharmaceutical Group Co. Ltd. A (688658) has a cash flow conversion efficiency ratio of 0.051x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥176.05 Million ≈ $25.76 Million USD) by net assets (CN¥3.43 Billion ≈ $501.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Youcare Pharmaceutical Group Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Youcare Pharmaceutical Group Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Youcare Pharmaceutical Group Co. Ltd. A carry for a breakdown of total debt and financial obligations.
Youcare Pharmaceutical Group Co. Ltd. A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Youcare Pharmaceutical Group Co. Ltd. A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Polestar Automotive Holding UK PLC Class A ADS
NASDAQ:PSNY
|
0.058x |
|
Cibus Nordic Real Estate AB (publ)
ST:CIBUS
|
0.025x |
|
Virgin Australia Holdings Ltd
AU:VGN
|
-0.244x |
|
Kuangda Technology Group Co Ltd
SHE:002516
|
0.026x |
|
ManpowerGroup Inc
NYSE:MAN
|
-0.051x |
|
Guardian Pharmacy Services, Inc.
NYSE:GRDN
|
0.144x |
|
Guizhou Zhenhua E chem Inc
SHG:688707
|
-0.024x |
|
Bank Islam Malaysia Bhd
KLSE:5258
|
0.146x |
Annual Cash Flow Conversion Efficiency for Youcare Pharmaceutical Group Co. Ltd. A (2017–2024)
The table below shows the annual cash flow conversion efficiency of Youcare Pharmaceutical Group Co. Ltd. A from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see Youcare Pharmaceutical Group Co. Ltd. A (688658) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.58 Billion ≈ $524.59 Million |
CN¥438.24 Million ≈ $64.13 Million |
0.122x | -44.01% |
| 2023-12-31 | CN¥3.60 Billion ≈ $526.45 Million |
CN¥785.49 Million ≈ $114.94 Million |
0.218x | +820.23% |
| 2022-12-31 | CN¥4.00 Billion ≈ $584.90 Million |
CN¥-121.17 Million ≈ $-17.73 Million |
-0.030x | -123.11% |
| 2021-12-31 | CN¥3.93 Billion ≈ $574.66 Million |
CN¥515.24 Million ≈ $75.40 Million |
0.131x | -32.57% |
| 2020-12-31 | CN¥3.59 Billion ≈ $524.73 Million |
CN¥697.66 Million ≈ $102.09 Million |
0.195x | -32.65% |
| 2019-12-31 | CN¥1.12 Billion ≈ $164.59 Million |
CN¥324.94 Million ≈ $47.55 Million |
0.289x | +26.35% |
| 2018-12-31 | CN¥842.76 Million ≈ $123.32 Million |
CN¥192.70 Million ≈ $28.20 Million |
0.229x | -24.22% |
| 2017-12-31 | CN¥711.86 Million ≈ $104.17 Million |
CN¥214.81 Million ≈ $31.43 Million |
0.302x | -- |
About Youcare Pharmaceutical Group Co. Ltd. A
Youcare Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It offers drugs in various forms, such as injection, lyophilized powder for injection, concentrated pills, tablets, capsules, gelatins, ointments, creams, granules, etc. The company provides drugs in various categories, including antibiotics, gastrointest… Read more